FOOD FOR THOUGHT
Including Prominent Hill's In Situ Value of around A$8 billion in my previous post numbers, the total In Situ Value for OZL's 3 producing/advanced projects is only 2 times HAV's In Situ Value for its 3 advanced projects.
Yet, the OZL market capitalisation is 34 times what HAV's was on Friday.
Neither OZL nor HAV has any debt.
Note: Carrapateena starts 470 metres below surface and has a vertical height of 1,000 metres. So 1.5 kms to the bottom.
Therefore, need higher grades, more Cu to make Carrapateena economic, given the huge CAPEX costs.
Cheers
These are only my random thoughts (if your dreams don't scare you, they are not big enough) and it does not constitute investment advice. Before acting on any information you read and before making any financial or investment decisions, you should always consult your advisor(s) or other relevant professional expert
- Forums
- ASX - By Stock
- HAV
- Havilah's Developing Projects
HAV
havilah resources limited
Add to My Watchlist
2.70%
!
18.0¢

Havilah's Developing Projects, page-4
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
18.0¢ |
Change
-0.005(2.70%) |
Mkt cap ! $61.06M |
Open | High | Low | Value | Volume |
18.5¢ | 18.5¢ | 18.0¢ | $27.66K | 153.5K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 2862 | 17.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
18.5¢ | 105784 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 2862 | 0.175 |
3 | 300500 | 0.170 |
7 | 324772 | 0.165 |
4 | 146506 | 0.160 |
3 | 246458 | 0.155 |
Price($) | Vol. | No. |
---|---|---|
0.185 | 105784 | 1 |
0.190 | 250333 | 4 |
0.195 | 219000 | 3 |
0.200 | 221010 | 5 |
0.230 | 10000 | 1 |
Last trade - 15.20pm 04/07/2025 (20 minute delay) ? |
Featured News
HAV (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online